Skip to main content
. 2010 Mar 21;2009:963037. doi: 10.1155/2009/963037

Figure 3.

Figure 3

Combined anti-CD25 immunotherapy prolongs the survival of glioma-bearing mice. Kaplan-Meier survival graph showing a significant increase in the median length of survival in mice (n = 10) treated with systemic and intratumoral anti-CD25 mAb (P < .005) and rechallenged with GL261.